Advances in mitochondria-targeted nanoparticles for lung cancer therapy
Frontiers in Cell and Developmental Biology · 09.11.2026 · 14
DOI: 10.3389/fcell.2026.1974613 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 09.11.2026. Verfasst von Zifan Meng und 4 weiteren Autor:innen. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lung cancer is one of the most commonly diagnosed and lethal malignancies worldwide. Although multimodal treatment has advanced substantially, therapeutic resistance, recurrence, and metastasis remain major clinical challenges. Mitochondria regulate cellular bioenergetics, redox homeostasis, and cell death and therefore contribute substantially to lung cancer development and progression. These functions make mitochondrial targeting a promising therapeutic strategy. However, mitochondrial delivery requires traversal of multiple biological barriers, and free drug molecules rarely accumulate efficiently within mitochondria. Nanoparticles offer tunable structures, high drug-loading capacity, and readily modifiable surfaces. By combining lung cancer cell targeting with mitochondrial targeting ligands, they can deliver drugs precisely to mitochondria in lung cancer cells. This review outlines mitochondrial vulnerabilities in lung cancer and summarizes mechanisms, design strategies, and recent advances in mitochondria-targeted nanoparticles. We also discuss their potential value and challenges for clinical translation.
Zitieren
APA
Meng, Z., Zhang, H., Liu, J., Wang, Y., & Zhang, G. (2026). Advances in mitochondria-targeted nanoparticles for lung cancer therapy. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1974613
Vancouver
Meng Z, Zhang H, Liu J, Wang Y, Zhang G. Advances in mitochondria-targeted nanoparticles for lung cancer therapy. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1974613
BibTeX
@article{Meng2026,
author = {Meng, Zifan and Zhang, Huan and Liu, Junfeng and Wang, Yicun and Zhang, Guangxin},
title = {Advances in mitochondria-targeted nanoparticles for lung cancer therapy},
journal = {Frontiers in Cell and Developmental Biology},
year = {2026},
volume = {14},
doi = {10.3389/fcell.2026.1974613}
}
EUVIMED